| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/06/2011 | EP2305232A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305231A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2303888A2 Methods and compounds for antimicrobial intervention |
| 04/06/2011 | EP2303846A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 04/06/2011 | EP2303845A2 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors |
| 04/06/2011 | EP2303836A1 Therapeutic cyclopentane derivatives |
| 04/06/2011 | EP2303335A1 Method of treating hearing loss using xiap |
| 04/06/2011 | EP2303287A1 Antiallergic marine biopolymers |
| 04/06/2011 | EP2303256A1 Compounds useful for the prevention or treatment of accomodative asthenopia |
| 04/06/2011 | EP2303227A2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 04/06/2011 | EP2303184A1 Combination treatment of glaucoma |
| 04/06/2011 | EP1303522B1 Biologically active macrolides, compositions, and uses thereof |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102006872A Ophthalmic preparation containing a pyridinol derivate |
| 04/06/2011 | CN102002104A Anti-VEGF monoclonal antibody and medicinal composition containing same |
| 04/06/2011 | CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 04/06/2011 | CN102000315A Traditional Chinese medicinal composition for treating dizziness and preparation method thereof |
| 04/06/2011 | CN102000314A Detection method of Chinese medicine composition for treating dizziness |
| 04/06/2011 | CN102000279A Traditional Chinese medicine for treating myopia eye diseases |
| 04/06/2011 | CN102000278A Traditional Chinese medicine for treating amblyopia eye diseases |
| 04/06/2011 | CN102000255A Plant formula for treating uveitis and preparation method thereof |
| 04/06/2011 | CN102000194A Traditional Chinese medicine composition for treating tympanitis and preparation method thereof |
| 04/06/2011 | CN102000038A Vinpocetine dispersible tablet and preparation method thereof |
| 04/06/2011 | CN101695540B Chinese medicament for treating cataract |
| 04/06/2011 | CN101596204B Compound fluconazole ointment and preparation method thereof |
| 04/06/2011 | CN101426487B Formulations containing amide derivatives of carboxylic acidnsaids for topical administration to the eye |
| 04/06/2011 | CN101390874B Eye health preparation |
| 04/06/2011 | CN101361892B Traditional Chinese medicine formulation for treating cataract and preparation method thereof |
| 04/06/2011 | CN101288679B Dissolving and reducing generation method of nano pearl powder |
| 04/06/2011 | CN101284030B Quality control methods of hairy holly root medicinal materials, extract or hairy holly root preparation |
| 04/06/2011 | CN101279046B Chinese medicinal composition for curing labyrinthine syndrome |
| 04/06/2011 | CN101167873B Technology for processing honey-prepared glutinous rehmannia |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2447909C Use of proteasome inhibitors to treat dry eye disorders |
| 03/31/2011 | WO2011037157A1 Eye drops |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036202A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit |
| 03/31/2011 | WO2010120566A3 METHODS FOR TREATING IgE-MEDIATED DISORDER |
| 03/31/2011 | WO2010093816A3 Gene therapy vector for treatment of steroid glaucoma |
| 03/31/2011 | US20110077306 Stat3 inhibiting compositions and methods |
| 03/31/2011 | US20110077304 1-aminocyclohexane derivatives for the treatment of cochlear tinnitus. |
| 03/31/2011 | US20110077270 Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure |
| 03/31/2011 | US20110077255 Substituted xanthine derivatives |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077244 Novel thiophenediamine derivative having urea structure |
| 03/31/2011 | US20110077240 Inhibitors of protein tyrosine kinase activity |
| 03/31/2011 | US20110077239 Glycine receptor agonists for the treatment of phantom phenomena |
| 03/31/2011 | US20110077229 Steroid Containing Drug Delivery Systems |
| 03/31/2011 | US20110077219 Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076320 Stem cell cultivation devices and methods |
| 03/31/2011 | US20110076318 Retinoid-containing sustained release intraocular implants and related matters |
| 03/31/2011 | US20110076314 Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom |
| 03/31/2011 | US20110076285 Methods and Compositions For Treatment of Ocular Fibrosis |
| 03/31/2011 | US20110076279 Fully human anti-vegf antibodies and methods of using |
| 03/31/2011 | US20110076278 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders |
| 03/31/2011 | US20110076267 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 03/31/2011 | US20110076266 Synergistic pharmaceutical composition useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animals |
| 03/31/2011 | CA2775039A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2772220A1 Eye drops |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301951A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 03/30/2011 | EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities |
| 03/30/2011 | EP2301583A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 03/30/2011 | EP2301580A1 Anti-VEGF antibodies |
| 03/30/2011 | EP2301561A1 Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders |
| 03/30/2011 | EP2301550A1 Tetracycline compounds having target therapeutic activities |
| 03/30/2011 | EP2301549A1 Remedies for diseases to be applied to eye |
| 03/30/2011 | EP2301541A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2300468A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido ý 3, 2, 1-i j¨quinoline compounds |
| 03/30/2011 | EP2300439A1 Therapeutic substituted hydantoins, and related compounds |
| 03/30/2011 | EP2300412A1 Prostaglandin produgs as hypotensive agents |
| 03/30/2011 | EP2299979A2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 03/30/2011 | EP2299976A2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 03/30/2011 | EP2299826A1 Compositions and methods for attenuating the formation of a2e in the retinal pigment epithelium |
| 03/30/2011 | CN1489583B Novel physiologically active substance |
| 03/30/2011 | CN101998989A Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
| 03/30/2011 | CN101998958A Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 03/30/2011 | CN101998863A Use of anti-amyloid beta antibody in ocular diseases |
| 03/30/2011 | CN101998854A Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/30/2011 | CN101991684A Chinese medicine composition for treating epicophosis and preparation method thereof |
| 03/30/2011 | CN101991671A Traditional Chinese medicine for treating diabetic eye disease |
| 03/30/2011 | CN101991612A Preparation method of haematococcus pluvialis extracts |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101991548A Reduced glutathione freeze-dried powder injection and preparation method thereof |
| 03/30/2011 | CN101991535A Docosahexaenoic acid (DHA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 03/30/2011 | CN101991534A EPA (eicoeapentaenoieaeid) ester fat emulsion intravenous injection and preparation method thereof |
| 03/30/2011 | CN101991111A Drug or heal-care food capable of alleviating visual fatigue |
| 03/30/2011 | CN101712649B Lotus leaf extract, monomer component and application thereof |
| 03/30/2011 | CN101569614B Puerarin lagging cover slowly-releasing dripping pill and preparing method thereof |
| 03/30/2011 | CN101242825B Use of L-carnitine and/or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 03/30/2011 | CN101073351B Memory-enhancing tea with brain-invigorating and vision-improving functions |
| 03/29/2011 | US7915312 Topical application to the eye of an acetylcholinesterase inhibitor such as echothiophate iodide to treat color blindness, ocular hypertension and glaucoma, and progression of myopia Strabismus Stargardts or pupil dilation. |